CoChat
Sign Up
Cited by 1,366

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Microglial and macrophage polarization—new prospects for brain repair

Hu, Xiaoming, Leak, Rehana K., Shi, Yejie, Suenaga, Jun, Gao, Yanqin, Zheng, Ping, Chen, Jun·2015·Nature Reviews Neurology
DOI 10.1038/nrneurol.2014.207PMC PMC4395497
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrneurol.2014.207

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 95

  1. Lo, E. H. Degeneration and repair in central nervous system disease. Nat. Med. 16, 1205–1209 (2010). · DOI
  2. Chu, M. et al. Focal cerebral ischemia activates neurovascular restorative dynamics in mouse brain. Front. Biosci. (Elite Ed.) 4, 1926–1936 (2012). · DOI
  3. Gutiérrez-Fernández, M. et al. Trophic factors and cell therapy to stimulate brain repair after ischaemic stroke. J. Cell. Mol. Med. 16, 2280–2290 (2012). · DOI
  4. Zhang, J. H. et al. The vascular neural network—a new paradigm in stroke pathophysiology. Nat. Rev. Neurol. 8, 711–716 (2012). · DOI
  5. Hanisch, U. K. & Kettenmann, H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10, 1387–1394 (2007). · DOI · Paper page
  6. Kwon, M. J. et al. Contribution of macrophages to enhanced regenerative capacity of dorsal root ganglia sensory neurons by conditioning injury. J. Neurosci. 33, 15095–15108 (2013). · DOI
  7. Liu, Z. et al. Chronic treatment with minocycline preserves adult new neurons and reduces functional impairment after focal cerebral ischemia. Stroke 38, 146–152 (2007). · DOI
  8. David, S. & Kroner, A. Repertoire of microglial and macrophage responses after spinal cord injury. Nat. Rev. Neurosci. 12, 388–399 (2011). · DOI · Paper page
  9. Moore, K. J., Sheedy, F. J. & Fisher, E. A. Macrophages in atherosclerosis: a dynamic balance. Nat. Rev. Immunol. 13, 709–721 (2013). · DOI · Paper page
  10. Boche, D., Perry, V. H. & Nicoll, J. A. Review: activation patterns of microglia and their identification in the human brain. Neuropathol. Appl. Neurobiol. 39, 3–18 (2013). · DOI
  11. Hu, X. et al. Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 43, 3063–3070 (2012). · DOI
  12. Wang, G. et al. Microglia/macrophage polarization dynamics in white matter after traumatic brain injury. J. Cereb. Blood Flow Metab. 33, 1864–1874 (2013). · DOI · Paper page
  13. Kigerl, K. A. et al. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci. 29, 13435–13444 (2009). · DOI · Paper page
  14. Thiel, A. & Heiss, W. D. Imaging of microglia activation in stroke. Stroke 42, 507–512 (2011). · DOI
  15. Perego, C., Fumagalli, S. & De Simoni, M. G. Temporal pattern of expression and colocalization of microglia/macrophage phenotype markers following brain ischemic injury in mice. J. Neuroinflammation 8, 174 (2011). · DOI
  16. Girard, S. et al. Microglia and macrophages differentially modulate cell death after brain injury caused by oxygen-glucose deprivation in organotypic brain slices. Glia 61, 813–824 (2013). · DOI
  17. Durafourt, B. A. et al. Comparison of polarization properties of human adult microglia and blood-derived macrophages. Glia 60, 717–727 (2012). · DOI
  18. Nakayama, D. et al. Injury-induced neural stem/progenitor cells in post-stroke human cerebral cortex. Eur. J. Neurosci. 31, 90–98 (2010). · DOI
  19. Lu, K. T. et al. Hippocampal neurogenesis after traumatic brain injury is mediated by vascular endothelial growth factor receptor-2 and the Raf/MEK/ERK cascade. J. Neurotrauma 28, 441–450 (2011). · DOI
  20. Hart, A. D., Wyttenbach, A., Perry, V. H. & Teeling, J. L. Age related changes in microglial phenotype vary between CNS regions: grey versus white matter differences. Brain Behav. Immun. 26, 754–765 (2012). · DOI · Paper page
  21. Norden, D. M. & Godbout, J. P. Review: microglia of the aged brain: primed to be activated and resistant to regulation. Neuropathol. Appl. Neurobiol. 39, 19–34 (2013). · DOI · Paper page
  22. Hickman, S. E. et al. The microglial sensome revealed by direct RNA sequencing. Nat. Neurosci. 16, 1896–1905 (2013). · DOI · Paper page
  23. Jung, S. & Schwartz, M. Non-identical twins—microglia and monocyte-derived macrophages in acute injury and autoimmune inflammation. Front. Immunol. 3, 89 (2012). · DOI
  24. Butovsky, O. et al. Microglia activated by IL-4 or IFN-γ differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol. Cell Neurosci. 31, 149–160 (2006). · DOI · Paper page
  25. Roughton, K., Andreasson, U., Blomgren, K. & Kalm, M. Lipopolysaccharide-induced inflammation aggravates irradiation-induced injury to the young mouse brain. Dev. Neurosci. 35, 406–415 (2013). · DOI
  26. Nikolakopoulou, A. M., Dutta, R., Chen, Z., Miller, R. H. & Trapp, B. D. Activated microglia enhance neurogenesis via trypsinogen secretion. Proc. Natl Acad. Sci. USA 110, 8714–8719 (2013). · DOI
  27. Yan, Y. P., Lang, B. T., Vemuganti, R. & Dempsey, R. J. Galectin-3 mediates post-ischemic tissue remodeling. Brain Res. 1288, 116–124 (2009). · DOI
  28. Choi, Y. S., Cho, H. Y., Hoyt, K. R., Naegele, J. R. & Obrietan, K. IGF-1 receptor-mediated ERK/MAPK signaling couples status epilepticus to progenitor cell proliferation in the subgranular layer of the dentate gyrus. Glia 56, 791–800 (2008). · DOI
  29. Kim, B. J. et al. Reduced neurogenesis after suppressed inflammation by minocycline in transient cerebral ischemia in rat. J. Neurol. Sci. 279, 70–75 (2009). · DOI
  30. Cafferty, W. B., McGee, A. W. & Strittmatter, S. M. Axonal growth therapeutics: regeneration or sprouting or plasticity? Trends Neurosci. 31, 215–220 (2008). · DOI
  31. Horn, K. P., Busch, S. A., Hawthorne, A. L., van Rooijen, N. & Silver, J. Another barrier to regeneration in the CNS: activated macrophages induce extensive retraction of dystrophic axons through direct physical interactions. J. Neurosci. 28, 9330–9341 (2008). · DOI
  32. Kitayama, M., Ueno, M., Itakura, T. & Yamashita, T. Activated microglia inhibit axonal growth through RGMa. PLoS ONE 6, e25234 (2011). · DOI
  33. Yin, Y. et al. Oncomodulin is a macrophage-derived signal for axon regeneration in retinal ganglion cells. Nat. Neurosci. 9, 843–852 (2006). · DOI
  34. Yin, Y. et al. Oncomodulin links inflammation to optic nerve regeneration. Proc. Natl Acad. Sci. USA 106, 19587–19592 (2009). · DOI
  35. Wake, H., Moorhouse, A. J., Jinno, S., Kohsaka, S. & Nabekura, J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J. Neurosci. 29, 3974–3980 (2009). · DOI · Paper page
  36. Zhan, Y. et al. Deficient neuron–microglia signaling results in impaired functional brain connectivity and social behavior. Nat. Neurosci. 17, 400–406 (2014). · DOI · Paper page
  37. Stevens, B. et al. The classical complement cascade mediates CNS synapse elimination. Cell 131, 1164–1178 (2007). · DOI · Paper page
  38. Medina, R. J. et al. Myeloid angiogenic cells act as alternative M2 macrophages and modulate angiogenesis through interleukin-8. Mol. Med. 17, 1045–1055 (2011). · DOI
  39. Zajac, E. et al. Angiogenic capacity of M1- and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9. Blood 122, 4054–4067 (2013). · DOI
  40. Welser, J. V., Li, L. & Milner, R. Microglial activation state exerts a biphasic influence on brain endothelial cell proliferation by regulating the balance of TNF and TGF-β1. J. Neuroinflammation 7, 89 (2010). · DOI
  41. Flögel, U. et al. In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging. Circulation 118, 140–148 (2008). · DOI
  42. Venneti, S., Lopresti, B. J. & Wiley, C. A. Molecular imaging of microglia/macrophages in the brain. Glia 61, 10–23 (2013). · DOI
  43. Chhor, V. et al. Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro. Brain Behav. Immun. 32, 70–85 (2013). · DOI
  44. Rolls, A. et al. Two faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activation. PLoS Med. 5, e171 (2008). · DOI
  45. Verma, S., Nakaoke, R., Dohgu, S. & Banks, W. A. Release of cytokines by brain endothelial cells: a polarized response to lipopolysaccharide. Brain Behav. Immun. 20, 449–455 (2006). · DOI
  46. Biswas, S. K. & Mantovani, A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 11, 889–896 (2010). · DOI · Paper page
  47. Beers, D. R. et al. Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis. Brain 134, 1293–1314 (2011). · DOI
  48. Starossom, S. C. et al. Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration. Immunity 37, 249–263 (2012). · DOI
  49. Jiang, M. H. et al. Substance P induces M2-type macrophages after spinal cord injury. Neuroreport 23, 786–792 (2012). · DOI
  50. Rocher, C. & Singla, D. K. SMAD–PI3K–Akt–mTOR pathway mediates BMP-7 polarization of monocytes into M2 macrophages. PLoS ONE 8, e84009 (2013). · DOI
  51. Gong, D. et al. TGFβ signaling plays a critical role in promoting alternative macrophage activation. BMC Immunol. 13, 31 (2012). · DOI
  52. Maiorino, C. et al. Lentiviral-mediated administration of IL-25 in the CNS induces alternative activation of microglia. Gene Ther. 20, 487–96 (2013). · DOI
  53. Sica, A. & Bronte, V. Altered macrophage differentiation and immune dysfunction in tumor development. J. Clin. Invest. 117, 1155–1166 (2007). · DOI
  54. Qin, H. et al. SOCS3 deficiency promotes M1 macrophage polarization and inflammation. J. Immunol. 189, 3439–3448 (2012). · DOI
  55. Martinez-Nunez, R. T., Louafi, F. & Sanchez-Elsner, T. The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor α1 (IL13Rα1). J. Biol. Chem. 286, 1786–1794 (2011). · DOI
  56. Sheldon, K. E. et al. Shaping the murine macrophage phenotype: IL-4 and cyclic AMP synergistically activate the arginase I promoter. J. Immunol. 191, 2290–2298 (2013). · DOI
  57. Koscsó, B. et al. Adenosine augments IL-10-induced STAT3 signaling in M2c macrophages. J. Leukoc. Biol. 94, 1309–1315 (2013). · DOI
  58. Qin, H. et al. Signal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammation. Proc. Natl Acad. Sci. USA 109, 5004–5009 (2012). · DOI
  59. Weis, N., Weigert, A., von Knethen, A. & Brüne, B. Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants. Mol. Biol. Cell 20, 1280–1288 (2009). · DOI
  60. Sanson, M., Distel, E. & Fisher, E. A. HDL induces the expression of the M2 macrophage markers arginase 1 and Fizz-1 in a STAT6-dependent process. PLoS ONE 8, e74676 (2013). · DOI
  61. Bouhlel, M. A. et al. PPARγ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab. 6, 137–143 (2007). · DOI · Paper page
  62. Hasegawa-Moriyama, M. et al. Peroxisome proliferator-activated receptor-γ agonist rosiglitazone attenuates inflammatory pain through the induction of heme oxygenase-1 in macrophages. Pain 154, 1402–1412 (2013). · DOI
  63. Zhao, X. et al. Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor γ in microglia/macrophages. Ann. Neurol. 61, 352–362 (2007). · DOI
  64. Satoh, T. et al. The Jmjd3–Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat. Immunol. 11, 936–944 (2010). · DOI · Paper page
  65. Krausgruber, T. et al. IRF5 promotes inflammatory macrophage polarization and TH1–TH17 responses. Nat. Immunol. 12, 231–238 (2011). · DOI
  66. Xu, H. et al. Notch–RBP-J signaling regulates the transcription factor IRF8 to promote inflammatory macrophage polarization. Nat. Immunol. 13, 642–650 (2012). · DOI
  67. Ruffell, D. et al. A CREB-C/EBPβ cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair. Proc. Natl Acad. Sci. USA 106, 17475–17480 (2009). · DOI · Paper page
  68. Ponomarev, E. D., Veremeyko, T. & Weiner, H. L. MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS. Glia 61, 91–103 (2013). · DOI · Paper page
  69. Cai, X. et al. Re-polarization of tumor-associated macrophages to pro-inflammatory M1 macrophages by microRNA-155. J. Mol. Cell Biol. 4, 341–343 (2012). · DOI
  70. Schulte, L. N., Westermann, A. J. & Vogel, J. Differential activation and functional specialization of miR-146 and miR-155 in innate immune sensing. Nucleic Acids Res. 41, 542–553 (2013). · DOI
  71. Guo, S. et al. IRF4 is a novel mediator for neuronal survival in ischaemic stroke. Cell Death Differ. 21, 888–903 (2014). · DOI
  72. Xiang, M. et al. Interferon regulatory factor 8 protects against cerebral ischaemic-reperfusion injury. J. Neurochem. 129, 988–1001 (2014). · DOI
  73. Hou, Y. C. et al. Preventive effect of silymarin in cerebral ischemia-reperfusion-induced brain injury in rats possibly through impairing NF-κB and STAT-1 activation. Phytomedicine 17, 963–973 (2010). · DOI
  74. Willemen, H. L. et al. MicroRNA-124 as a novel treatment for persistent hyperalgesia. J. Neuroinflammation 9, 143 (2012). · DOI · Paper page
  75. Desestret, V. et al. In vitro and in vivo models of cerebral ischemia show discrepancy in therapeutic effects of M2 macrophages. PLoS ONE 8, e67063 (2013). · DOI
  76. Mikita, J. et al. Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult. Scler. 17, 2–15 (2011). · DOI · Paper page
  77. Zhu, W. et al. Insulin growth factor-1 gene transfer enhances neurovascular remodeling and improves long-term stroke outcome in mice. Stroke 39, 1254–1261 (2008). · DOI
  78. Courties, G. et al. In vivo silencing of the transcription factor IRF5 reprograms the macrophage phenotype and improves infarct healing. J. Am. Coll. Cardiol. 63, 1556–1566 (2014). · DOI
  79. Hall, J. L. & Wei, L. N. Could silencing IRF5 improve healing of a myocardial infarct through the reprogramming of the macrophage population? J. Am. Coll. Cardiol 63, 1567–1568 (2014). · DOI
  80. Eames, H. L. et al. KAP1/TRIM28: an inhibitor of IRF5 function in inflammatory macrophages. Immunobiology 217, 1315–1324 (2012). · DOI
  81. Xiong, X. et al. Increased brain injury and worsened neurological outcome in interleukin-4 knockout mice after transient focal cerebral ischemia. Stroke 42, 2026–2032 (2011). · DOI
  82. Boehler, R. et al. Lentivirus delivery of IL-10 to promote and sustain macrophage polarization towards an anti-inflammatory phenotype. Biotechnol. Bioeng. 111, 1210–1221 (2014). · DOI
  83. Zhao, B. Q. et al. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat. Med. 12, 441–445 (2006). · DOI
  84. Hanania, R. et al. Classically activated macrophages use stable microtubules for matrix metalloproteinase-9 (MMP-9) secretion. J. Biol. Chem. 287, 8468–8483 (2012). · DOI
  85. Komohara, Y., Ohnishi, K., Kuratsu, J. & Takeya, M. Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J. Pathol. 216, 15–24 (2008). · DOI · Paper page
  86. Planas, A. M., Justicia, C. & Ferrer, I. Stat1 in developing and adult rat brain. Induction after transient focal ischemia. Neuroreport 8, 1359–1362 (1997). · DOI
  87. Wu, Y., Yang, L., Mei, X. & Yu, Y. Selective inhibition of STAT1 reduces spinal cord injury in mice. Neurosci. Lett. 580, 7–11 (2013). · DOI
  88. Liu, D. Z. et al. Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J. Cereb. Blood Flow Metab. 30, 92–101 (2010). · DOI
  89. Luo, Y. et al. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone. J. Neurochem. 97, 435–448 (2006). · DOI
  90. Erdö, F., Trapp, T., Mies, G. & Hossmann, K. A. Immunohistochemical analysis of protein expression after middle cerebral artery occlusion in mice. Acta Neuropathol. 107, 127–136 (2004). · DOI
  91. Shrivastava, K. et al. Temporal expression of cytokines and signal transducer and activator of transcription factor 3 activation after neonatal hypoxia/ischemia in mice. Dev. Neurosci. 35, 212–225 (2013). · DOI
  92. Bouhy, D. et al. Delayed GM-CSF treatment stimulates axonal regeneration and functional recovery in paraplegic rats via an increased BDNF expression by endogenous macrophages. FASEB J. 20, 1239–1241 (2006). · DOI
  93. Batchelor, P. E. et al. Macrophages and microglia produce local trophic gradients that stimulate axonal sprouting toward but not beyond the wound edge. Mol. Cell. Neurosci. 21, 436–453 (2002). · DOI
  94. Ardelt, A. A., Bhattacharyya, B. J., Belmadani, A., Ren, D. & Miller, R. J. Stromal derived growth factor-1 (CXCL12) modulates synaptic transmission to immature neurons during post-ischemic cerebral repair. Exp. Neurol. 248, 246–253 (2013). · DOI
  95. Yan, Y. P., Lang, B. T., Vemuganti, R. & Dempsey, R. J. Osteopontin is a mediator of the lateral migration of neuroblasts from the subventricular zone after focal cerebral ischemia. Neurochem. Int. 55, 826–832 (2009). · DOI

Cited by

Sorted by citations

See all 1,366

Metadata

Authors
Hu, X., Leak, R. K., Shi, Y., Suenaga, J., Gao, Y., Zheng, P., & Chen, J.
Venue
Nature Reviews Neurology
Publisher
Springer Science and Business Media LLC
Published
2014-11-11
Volume
11
Issue
1
Pages
56-64
ISSN
  • 1759-4758
  • 1759-4766
DOI
10.1038/nrneurol.2014.207
PMC
PMC4395497
Cited by
1,366
References
20
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review